Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project by Philip J Mease, Fabian Proft, Murat Torgutalp, Shikha Singla, Andre Ribeiro

Get full text

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research by Désirée van der Heijde, Dafna D. Gladman, Arthur Kavanaugh, Philip J. Mease

Get full text

Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in pati... by William Tillett, Laura C. Coates, Sandeep Kiri, Vanessa Taieb, Damon Willems, Philip J. Mease

Get full text

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis by Alexis Ogdie, Dafna D. Gladman, Laura C. Coates, Effie Pournara, Bhumik Parikh, Philip J. Mease

Get full text

Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-... by Philip J Mease, Dafna D Gladman, Laura C Coates, Sandra Navarra, Corine Gaillez, Weibin Bao

Get full text

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial by Vibeke Strand, Evo Alemao, Thomas Lehman, Alyssa Johnsen, Subhashis Banerjee, Harris A. Ahmad, Philip J. Mease

Get full text

Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap by Atul Deodhar, Lianne S. Gensler, Marina Magrey, Jessica A. Walsh, Adam Winseck, Daniel Grant, Philip J. Mease

Get full text

Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries by Philip J. Mease, Mei Liu, Sabrina Rebello, Hyungjoo Kang, Esther Yi, Yujin Park, Jeffrey D. Greenberg

Get full text

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North Amer... by Philip J. Mease, Scott Stryker, Mei Liu, Bob Salim, Sabrina Rebello, Mahdi Gharaibeh, David H. Collier

Get full text

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry by Philip J. Mease, Pamela Young, Lara Fallon, Rajiv Mundayat, Oluwaseyi Dina, Taylor Blachley, Nicole Middaugh, Alexis Ogdie

Get full text

Real‐World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry by Philip J. Mease, Jacqueline O'Brien, Nicole Middaugh, Gregory Kricorian, Scott Stryker, David H. Collier, Alexis Ogdie

Get full text

What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives by Philip J. Mease, M. Elaine Husni, Evan Siegel, Daniel E. Furst, Melissa Mcilraith, Vibeke Strand, M. Cameron Hay

Get full text

Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies by Ana-Maria Orbai, Philip J. Mease, Philip S. Helliwell, Oliver FitzGerald, Dona L. Fleishaker, Rajiv Mundayat, Pamela Young

Get full text

Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized c... by Dafna D. Gladman, Peter Nash, Philip J. Mease, Oliver FitzGerald, Stephanie Duench, Mary Jane Cadatal, Karim R. Masri

Get full text

Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry by Philip J. Mease, Mei Liu, Sabrina Rebello, Winnie Hua, Robert R. McLean, Esther Yi, Yujin Park, Alexis Ogdie

Get full text

Discontinuation and switching patterns of tumour necrosis factor inhibitors (TNFis) in TNFi-naive and TNFi-experienced patients with psoriatic arthritis: an observational study fro... by Philip J Mease, Jeffrey D Greenberg, Chitra Karki, Mei Liu, YouFu Li, Bernice Gershenson, Hua Feng, Peter Hur

Get full text

Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry by Philip J. Mease, Andrew Blauvelt, Adam P. Sima, Silky W. Beaty, Robert Low, Braulio Gomez, Marie Gurrola, Mark G. Lebwohl

Get full text

Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen‐B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloa... by Philip J. Mease, Soumya D. Chakravarty, Robert R. McLean, Taylor Blachley, Toana Kawashima, Iris Lin, Arthur Kavanaugh, Alexis Ogdie

Get full text

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies by Philip J. Mease, Ana-Maria Orbai, Oliver FitzGerald, Mohamed Bedaiwi, Dona L. Fleishaker, Rajiv Mundayat, Pamela Young, Philip S. Helliwell

Get full text

Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison by Philip J. Mease, Richard B. Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Vanessa Taieb, Jason Eells, Iain B. McInnes

Get full text